Pacific Diabetes Technologies

Portland, OR · Founded 2013 · Privately Held (backing)

Developer of hollow glucose sensor devices designed for continuous glucose monitoring and insulin delivery. Pacific Diabetes Technologies is based in Portland, OR and was founded in 2013. Its last reported valuation was $30.7 million in Mar 2025. It has raised $17.6 million across 3 recorded rounds; the latest was a $3.4 million seed round in Oct 2025.

Last reported valuation
$30.7M
Oct 2026
Priced at
—
Total raised
$17.6M
Last round
Seed Round
Oct 2025
What is Pacific Diabetes Technologies worth?
$30.7Mlast reported valuation · Oct 2026

Pacific Diabetes Technologies's last reported valuation, Mar 2025. Nothing priced has surfaced since.

Free account
More of Pacific Diabetes Technologies with a free account
  • ·Watch Pacific Diabetes Technologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Pacific Diabetes Technologies funding history

3 rounds
DateRoundRaisedPost-money
Oct 2025Seed Round$3.4M▮
Mar 2025Seed Round$2.1M▮
Sep 2023Seed Round$1.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Pacific Diabetes Technologies valuation

Pacific Diabetes Technologies's last reported valuation was $30.7 million in Mar 2025. No priced round, secondary trade or fund mark has surfaced since.

How much has Pacific Diabetes Technologies raised?

Pacific Diabetes Technologies has raised $17.6 million in total; 3 of its rounds are on record, from 2023 on. The largest on record was a $3.4 million seed round in Oct 2025.

Pacific Diabetes Technologies has filed 5 Form Ds with the SEC since 2021, most recently in Nov 2025 ($3.4 million sold to 15 investors).

How Pacific Diabetes Technologies's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Pacific Diabetes Technologies, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Pacific Diabetes Technologies

What is Pacific Diabetes Technologies worth?
Pacific Diabetes Technologies is valued at $30.7M as of Oct 2026. Pacific Diabetes Technologies's last reported valuation, Mar 2025. Nothing priced has surfaced since.
How much has Pacific Diabetes Technologies raised?
Pacific Diabetes Technologies has raised $17.6M in total funding across 3 recorded rounds.
When did Pacific Diabetes Technologies last raise?
Pacific Diabetes Technologies last raised in Oct 2025 (Seed Round), raising $3.4M.